Rhythm Pharmaceuticals (RYTM) PT Lowered to $45 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Alan Carr lowered the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $45.00 (from $50.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
